Research professionals are encouraged to use the contact information on the "Our Team" page of this site to get in touch with members of the NCPC team, or email us at ncpc@northwestern.edu for more information about chemoprevention trials.
Information regarding previous publications and findings can be found in the "Completed Trials" section of our website.
Do you have
Liver Cirrhosis?
Liver cancer rates are increasing in the United States, and elsewhere. Out of every 100 patients with liver cancer, only 18 will survive for 5 years or more. An important cause of liver cancer is liver cirrhosis, which results from hepatitis infections, fatty liver, or alcohol use. Currently, there are no known preventive medications that could reduce the risk of liver cancer in people with cirrhosis.
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Patients With Cirrhosis
Principal Investigator: A. Ruth He, M.D.
Georgetown University
This study is no longer accepting patients. To learn more about this study, please visit:
Additional Resources
Informational Handout
QR Poster
Study Poster
About Polyphenon E®
Simvastatin in Preventing Liver Cancer in Patients with Liver Cirrhosis
Principal Investigator: Marc T. Goodman, Ph.D, M.P.H.
Cedars-Sinai Medical Center
This study is no longer accepting patients. To learn more about this study, please visit https://clinicaltrials.gov/ct2/show/NCT02968810?term=goodman&cond=Liver+Cirrhosis&draw=2&rank=1
Additional Resources
Study Brochure
Cedars-Sinai Medical Center
Study Brochure
Northwestern University
Statins & Liver Health
Estatinas y salud hepática